Clinical Pharmacology

	12/14/2009	Intravitreal Triamcinolone May Slow Progression of Diabetic Retinopathy - (DGNews)
	12/14/2009	Exemestane Therapy Show Unfavourable Changes in Lipid Profile: Presented at SABCS - (DGDispatch)
	12/14/2009	Bevacizumab Plus Docetaxel Improves Progression-Free Survival, but Not Overall Survival in Metastatic Breast Cancer: Presented at SABCS - (DGDispatch)
	12/14/2009	Adding Bevacizumab to Second-Line Chemo Improves Progression-Free Survival in Metastatic Breast Cancer: Presented at SABCS - (DGDispatch)
	12/14/2009	FDA Approves Long-Acting Olanzapine Intramuscular Injection for Schizophrenia - (DGNews)
	12/14/2009	Switching to an Aromatase Inhibitor at Year 5 of Tamoxifen Therapy Reduces Breast Cancer Recurrence: Presented at SABCS - (DGDispatch)
	12/14/2009	Contraindicated medication use in dialysis patients undergoing percutaneous coronary intervention (JAMA)
	12/13/2009	ACE Inhibitors and ARBs May Protect Against Breast Cancer Recurrence: Presented at SABCS - (DGDispatch)
	12/13/2009	Neratinib/Paclitaxel Combination Shows Promise in Metastatic Breast Cancer: Presented at SABCS - (DGDispatch)
	12/13/2009	Adjuvant Trastuzumab With Chemotherapy for 1 Year Delays Breast Cancer Progression: Presented at SABCS - (DGDispatch)
	12/12/2009	Docetaxel Plus Capecitabine Shows More Benefit as First-Line Therapy for Metastatic Breast Cancer Than Docetaxel Plus Epirubicin: Presented at SABCS - (DGDispatch)
	12/12/2009	No Survival Benefit for 5-FU/Docetaxel After Preoperative Epirubicin/Cyclophosphamide in Inflammatory Breast Cancer: Presented at SABCS - (DGDispatch)
	12/12/2009	Adding Bevacizumab to Second-Line Chemo Improves Progression-Free Survival in Metastatic Breast Cancer: Presented at SABCS - (DGDispatch)
	12/12/2009	Adding Lapatinib, Continuing Trastuzumab Despite Progression Adds Months to Breast Cancer Survival: Presented at SABCS - (DGDispatch)
	12/11/2009	Ibandronate Offers Pain Relief With Renal Safety in Women With Breast Cancer, Metastatic Bone Disease: Presented at SABCS - (DGDispatch)
	12/11/2009	Exemestane for 5 Years Not Superior to Tamoxifen Followed by Exemestane for Breast Cancer: Presented at SABCS - (DGDispatch)
	12/11/2009	No Cardiac Safety Problems When Casopitant Is Given With Anthracycline for Malignant Solid Tumours: Presented at SABCS - (DGDispatch)
	12/11/2009	High-Dose Fulvestrant Postpones Disease Progression in Advanced Breast Cancer: Presented at SABCS - (DGDispatch)
	12/11/2009	Antithrombotics Increase Risk of Hospital Admission for Bleeding in MI Patients - (DGNews)
	12/11/2009	Pregnancy Does Not Worsen Outcomes Among Women With Breast Cancer: Presented at SABCS - (DGDispatch)
	12/11/2009	Optimal Duration of Neoadjuvant Letrozole Longer Than the Traditional 4 Months to Permit Breast-Conserving Surgery: Presented at SABCS - (DGDispatch)
	12/11/2009	Letrozole Superior to Tamoxifen in Hormone Receptor-Positive Early Breast Cancer: Presented at SABCS - (DGDispatch)
	12/11/2009	Febrile Neutropenia Occurs More Frequently in Real World Setting Than in Clinical Trials: Presented at SABCS - (DGDispatch)
	12/11/2009	Lapatinib Plus Nab-Paclitaxel Shows Promise for HER2-Positive Breast Cancer: Presented at SABCS - (DGDispatch)
	12/11/2009	Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis (BMJ)
	12/10/2009	Low-Molecular-Weight Heparin Reduces Risk of Venous Clots in Patients With Pancreatic Cancer: Presented at ASH - (DGDispatch)
	12/10/2009	Extended-Release Lamotrigine Monotherapy Effective, May Be Accompanied by Serious Adverse Effects: Presented at AES - (DGDispatch)
	12/10/2009	Paediatric Patients With Absence Epilepsy Show High Seizure-Free Rates on Lamotrigine as Monotherapy: Presented at AES - (DGDispatch)
	12/10/2009	Blood Stem-Cell Transplant Regimen Reverses Sickle Cell Disease in Adults - (DGNews)
	12/10/2009	Once-Daily Enoxaparin Feasible in Some Children at Risk of Venous Thromboembolism: Presented at ASH - (DGDispatch)